Using a case-crossover design with MarketScan claims data (2001–2023), this study estimated the incidence and duration of diagnostic delays for measles among 4,651 U.S. cases by examining healthcare encounters in the two weeks before confirmed diagnosis.
About 6.9% (95% CI: 6.1–8.0%) of patients had at least one missed diagnostic opportunity, with a mean delay of 4.05 days (95% CI: 3.48–4.51); 1.7% experienced delays ≥1 week. Delays occurred most often in outpatient settings (81%), and age <2 years and antibiotic prescriptions were associated with higher likelihood of delay.
Claims data cannot confirm true clinical presentation or clinician reasoning, so 'missed opportunities' are inferred from billed diagnoses and symptoms rather than chart review. The MarketScan database skews toward commercially insured populations, potentially underrepresenting uninsured or Medicaid patients who may have different care-seeking patterns.
Clinicians—especially in outpatient settings—should keep measles on the differential for febrile rash illness, particularly in children under 2 years, and resist anchoring on antibiotic-responsive conditions before ruling out measles. Early recognition shortens the infectious window and limits transmission.